Artrya Limited (AYA.AX)

AUD 0.67

(0.75%)

EBITDA Summary of Artrya Limited

  • Artrya Limited's latest annual EBITDA in 2024 was -13.95 Million AUD , down -32.8% from previous year.
  • Artrya Limited's latest quarterly EBITDA in 2024 FY was N/A , down -35.22% from previous quarter.
  • Artrya Limited reported an annual EBITDA of -10.5 Million AUD in 2023, up 27.66% from previous year.
  • Artrya Limited reported an annual EBITDA of -16.39 Million AUD in 2022, down -290.61% from previous year.
  • Artrya Limited reported a quarterly EBITDA of N/A for 2024 FY, down -35.22% from previous quarter.
  • Artrya Limited reported a quarterly EBITDA of -3037.00 AUD for 2024 Q1, up 30.01% from previous quarter.

Annual EBITDA Chart of Artrya Limited (2024 - 2019)

Historical Annual EBITDA of Artrya Limited (2024 - 2019)

Year EBITDA EBITDA Growth
2024 -13.95 Million AUD -32.8%
2023 -10.5 Million AUD 27.66%
2022 -16.39 Million AUD -290.61%
2021 -4.01 Million AUD -140.94%
2020 -1.33 Million AUD -1097.9%
2019 -145.57 Thousand AUD 0.0%

Peer EBITDA Comparison of Artrya Limited

Name EBITDA EBITDA Difference
Alcidion Group Limited -4.49 Million AUD -210.387%
Beamtree Holdings Limited -331 Thousand AUD -4116.012%
Cogstate Limited 9.89 Million AUD 241.084%
Careteq Limited -826.61 Thousand AUD -1588.208%
Doctor Care Anywhere Group PLC -8.35 Million AUD -67.046%
Emyria Limited -13.03 Million AUD -7.059%
Global Health Limited -1.76 Million AUD -690.305%
HITIQ Limited -2.54 Million AUD -448.843%
Intelicare Holdings Limited -3.02 Million AUD -362.007%
ImExHS Limited -1.25 Million AUD -1009.547%
Mach7 Technologies Limited -2.44 Million AUD -471.448%
MedAdvisor Limited 7.04 Million AUD 297.991%
Oakridge International Limited -630.05 Thousand AUD -2114.893%
Opyl Limited -3.2 Million AUD -334.837%
PainChek Limited -9.48 Million AUD -47.073%
Pro Medicus Limited 120.76 Million AUD 111.556%
Resonance Health Limited -457 Thousand AUD -2953.557%
Singular Health Group Ltd -2.88 Million AUD -383.686%
Total Brain Limited -5.49 Million AUD -154.137%